# FDA Inspection 760924 - Biomat USA, Inc - December 22, 2011

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4ea366fe-334d-4da2-85e7-9d85f2d47563
Source feed: FDA_Inspections

> FDA Inspection 760924 for Biomat USA, Inc on December 22, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 760924
- Company Name: Biomat USA, Inc
- Inspection Date: 2011-12-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1153161 - 2021-09-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/1adf700c-120a-4dcc-b57a-93fd53ebe1e6)
- [FDA Inspection 1153161 - 2021-09-23](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6253c68a-bbc0-4c7b-b2d9-29d83a86c74c)
- [FDA Inspection 1009636 - 2017-04-07](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/16399d43-eec0-4465-bd3c-bc4b43d39b0b)
- [FDA Inspection 870408 - 2014-03-12](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/999c2e6a-69cf-4511-85e0-aff41814c472)

Company: https://www.keypedia.com/companies/biomat-usa-inc/cc1eb067-768e-4b7c-8144-628a7d51c86b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d